Figure S1 from Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)
Abstract
Figure S1. Seventeen patients were tested with IFN-γ ELISPOT assay.Keywords
This publication has 0 references indexed in Scilit: